Gene: SLC48A1
Official Full Name: solute carrier family 48 member 1provided by HGNC
Gene Summary: Enables heme binding activity and heme transmembrane transporter activity. Involved in heme transport. Located in endosome membrane; lysosomal membrane; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20122 | SLC48A1 Knockout cell line (HeLa) | Human | SLC48A1 | 1:3~1:6 | Negative | Online Inquiry |
KO20123 | SLC48A1 Knockout cell line (HCT 116) | Human | SLC48A1 | 1:2~1:4 | Negative | Online Inquiry |
KO20124 | SLC48A1 Knockout cell line (HEK293) | Human | SLC48A1 | 1:3~1:6 | Negative | Online Inquiry |
KO20125 | SLC48A1 Knockout cell line (A549) | Human | SLC48A1 | 1:3~1:4 | Negative | Online Inquiry |
The SLC48A1 Gene Knockout Cell Lines are specifically engineered cellular models that lack the SLC48A1 gene, which encodes a heme transporter known to play a crucial role in iron metabolism and cellular stress responses. By disabling this gene, researchers can investigate the physiological and pathological implications of SLC48A1 dysfunction, particularly in contexts relevant to iron homeostasis, redox balance, and potential links to various diseases, including anemia and neurodegenerative conditions.
The primary function of these cell lines is to facilitate the study of the consequences of SLC48A1 deletion on cellular behavior, signaling pathways, and metabolic adaptations. By utilizing loss-of-function models, scientists can delineate the specific roles of SLC48A1 in heme transport and thus dissect its contribution to cellular iron overload and oxidative stress. This mechanistic insight enables the exploration of how variations in heme availability may influence processes such as cell proliferation, apoptosis, and differentiation.
The SLC48A1 Gene Knockout Cell Lines are invaluable tools in both research and clinical settings. They allow for high-throughput screening of potential therapeutic compounds targeting iron metabolism pathways, thereby contributing to the development of innovative treatment strategies for conditions associated with dysregulated iron homeostasis.
Compared to traditional cell lines that express SLC48A1, these knockout models provide a distinct advantage by minimizing confounding variables, which enhances the validity of experimental results. The specificity of the knockout facilitates clearer interpretations of data, ultimately leading to more robust conclusions in iron biology studies.
For researchers, clinicians, and pharmaceutical developers, these cell lines represent a critical resource for advancing our understanding of heme and iron metabolism. Their unique properties make them an essential addition to the toolkit of any laboratory focused on cellular stress responses or iron-related pathologies.
Our company is recognized for its commitment to innovation and scientific excellence in providing high-quality biological products. We strive to support the scientific community's pursuit of knowledge and breakthroughs by offering advanced research tools like the SLC48A1 Gene Knockout Cell Lines, engineered to empower cutting-edge research and facilitate significant discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.